About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Pcmt1tm1Shs
targeted mutation 1, Takuji Shirasawa
MGI:2384158
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Pcmt1tm1Shs/Pcmt1tm1Shs involves: 129P2/OlaHsd * C57BL/6 MGI:3623343


Genotype
MGI:3623343
hm1
Allelic
Composition
Pcmt1tm1Shs/Pcmt1tm1Shs
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pcmt1tm1Shs mutation (2 available); any Pcmt1 mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• ~50% of homozygotes die spontaneously at 4 to 5 weeks of age; the remaining ~50% die at a rather constant rate until 13 weeks of age
• survival can be extended by an average of 4 weeks by oral administration of the antiepileptic drug DPA (3 mg/ml); however, epileptic attacks that are initially controlled by DPA become uncontrollable by 12 weeks of age

nervous system
• homozygotes die from grand mal-type epileptic attacks with jumping fits or refractory status epilepticus
• epileptic seizures include jumping fits, forelimb clonus, running fits, tonic-clonic seizures, and myoclonic jerks of the limbs and the trunk
• the frequency of epileptic seizures is significantly reduced until 7-8 weeks by oral administration of DPA
• at 5 weeks, homozygotes show a proportional enlargement of the gray matter and white matter of the cerebral cortex, hippocampus, striatum, thalamus, and cerebellum; no significantly increased numbers of neurons, astrocytes or oligodendrocytes are observed
• mutant brain volume begins to increase after 4 weeks of age until it finally reaches an average of ~25% increase at ~10 weeks
• homozygous mutant brains are 15% heavier than those of heterozygous mutant mice
• homozygotes display aberrant cortical pyramidal neuron morphology, with an abnormally ballooned nucleus and a clearly demarcated nucleolus in layer V
• apical dendrites of mutant pyramidal neurons in layers II and III of the cerebral cortex display twisted configurations with abnormal winding and bifurcations in the proximal portion
• in addition, dendrites of mutant pyramidal neurons show disorganized microtubules with bundles being unevenly or peripherally localized inside the dendritic fibers
• pyramidal cells in layer III of the mutant cerebral cortex display a slight reduction in axon diameter
• pyramidal cells in layer III of the mutant cerebral cortex display a slight reduction in axon diameter
• homozygotes exhibit clinical convulsions with EEG recordings of paroxysmal cortical discharges

homeostasis/metabolism
• homozygotes display an increased blood urea nitrogen level relative to wild-type mice (30.3 vs 19.7 mg/dl)
• homozygotes show increased levels of corticosterone relative to wild-type mice (0.24 vs 0.12 mg/ml)
• homozygotes show normal levels of free T3 and T4 but increased levels of aldosterone relative to wild-type mice (830 vs 430 pg/ml)
• homozygotes exhibit decreased levels of total cholesterol (86 vs 116 mg/dl) and esterified cholesterol (75 vs 105 mg/dl)
• homozygotes show normal levels of phospholipid and free fatty acids but an increased level of triglycerides relative to wild-type mice (70 vs 52 mg/dl)
• homozygotes show normal levels for Na, K, Cl, Ca, and creatinine but a reduced phosphate level relative to wild-type mice (9.8 vs 12.1 mg/dl)
• homozygotes exhibit reduced levels of creatine phosphokinase relative to wild-type mice (1138 vs 2135 IU/l)
• in contrast, levels of total protein, albumin, glutamic-oxaloacetic transaminase, glutamic-pyruvic transaminase, alkaline phosphatase, and cholinesterase remain normal
• homozygotes exhibit reduced blood levels of lactate dehydrogenase relative to wild-type mice (996 vs 1306 IU/l, respectively)
• homozygotes display reduced ferritin levels relative to wild-type mice (2.5 vs 5.2 ng/ml)

behavior/neurological
• homozygotes die from grand mal-type epileptic attacks with jumping fits or refractory status epilepticus
• epileptic seizures include jumping fits, forelimb clonus, running fits, tonic-clonic seizures, and myoclonic jerks of the limbs and the trunk
• the frequency of epileptic seizures is significantly reduced until 7-8 weeks by oral administration of DPA

growth/size/body
• homozygotes display a ~35% decrease in body weight until 7 weeks after birth

hematopoietic system
• homozygous mutant spleens are 28% smaller than those of heterozygous mutant mice

skeleton
• ~20% of homozygotes display kyphosis of the spine, with no abnormalities found in the bones of vertebrae, skulls, or limbs

immune system
• homozygous mutant spleens are 28% smaller than those of heterozygous mutant mice

muscle

respiratory system
• homozygotes exhibit respiratory arrests after grand mal attacks

cellular
• homozygotes exhibit significant accumulation of L-isoaspartyl residues in the brain, testis, heart, muscle, spleen, and eyes
• in contrast, D-aspartate residues appear to be slightly decreased in mutant brain





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory